NEW ORLEANS, March 17, 2014 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 13, 2014 to file lead plaintiff applications in a securities class action lawsuit against Geron Corporation (Nasdaq:GERN), if they purchased the Company's securities during the period between June 16, 2013 and March 11, 2014, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
What You May Do
If you purchased shares of Geron and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850, or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com) or KSF Partner Melinda Nicholson (melinda.nicholson@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by May 13, 2014.
About the Lawsuit
Geron and certain of its executives are charged with issuing a series of materially false and misleading statements during the Class Period, violating federal securities laws.
On March 12, 2014, Geron announced that the Company has received verbal notice from the U.S. Food and Drug Administration ("FDA") that its investigational new drug application for its only experimental drug, imetelstat for blood disorders, has been placed on full clinical hold, affecting its mid-stage trials of imetelstat because of low-grade liver function test abnormalities. The FDA expressed concern about whether these LFT abnormalities are reversible.
On this news, the price of Geron's shares plummeted by over 61%.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.